Agenus Inc (AGEN): Total Assets
$226.80M
As of 2025-12-31
$172.69M
As of 2026-06-30
-18.1%
3-year compound annual growth
+1.1%
5-year compound annual growth
-0.7%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $226.80M | +0.2% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $226.27M | -27.9% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $313.91M | -24.1% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $413.56M | -11.2% | 2024-03-14, Balance as of period end |
| 2021-12-31 | $465.96M | +117.2% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $214.51M | +38.1% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $155.34M | +13.9% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $136.40M | -1.4% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $138.40M | -11.8% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $156.99M | -35.2% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $242.23M | +225.0% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $74.53M | +113.9% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $34.84M | +19.7% | 2015-03-16, Balance as of period end |
| 2012-12-31 | $29.09M | +46.9% | 2014-03-07, Balance as of period end |
| 2011-12-31 | $19.81M | -35.9% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $30.91M | n/a | 2012-03-06, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Agenus Inc (AGEN) | 2025-12-31 | $226.80M | +0.2% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $501.90M | +31.1% |
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | $223.70M | -36.7% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $20.23M | -81.5% |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $448.66M | +2.3% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $173.83M | -55.1% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $1.48B | +34.2% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $566.71M | +1.1% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $244.43M | -9.4% |
Compare AGEN, IBRX, IPSC, ATRA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗